By proceeding, you agree to our Terms of Use and Privacy Policy.
Over the past couple of years, the engineered biology market has seen fledgling companies rise to IPO smashing power players, as the demand for high-quality, engineered biomolecules and controllable therapeutics grows exponentially.
The summit will dive into scalable engineered & synthetic biology-based therapeutics, and technical challenges that lie ahead in the path towards commercialization.
Don't miss the chance to up-skill, mingle & network with top industry experts like Mark Kotter- CEO, bit.bio, Tim Lu- CEO, Senti Biosciences & more.
Learn from industry trailblazers at Arsenal Biosciences, bit.bio, MIT, Novome Bio & more, to help develop effective synthetic biology-based therapeutics.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Very good conference, excellent content and lots of good networking.
Synthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health.
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.